
PerkinElmer Inc.
PKI | NYSE
$115.24
$0.00 (0.00%)
Nov 2, 2026, 12:49 PM ET · Market open
Company Profile
PerkinElmer, Inc. operates as a global enterprise delivering innovative products, specialized services, and comprehensive solutions across the diagnostics, life sciences, and applied technology sectors. The company's operations are divided into two main segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions division furnishes scientists with an extensive suite of offerings, including chemical reagents, informatics platforms, and cutting-edge detection and imaging technologies. These resources are designed to accelerate research breakthroughs in the life sciences, and the segment also provides contract research and laboratory services. Additionally, it supplies analytical technologies, integrated solutions, and expert services to clients in the environmental, food, and industrial markets, aiding in the assessment and characterization of air, water, and soil quality. This segment further supports agricultural producers and food manufacturers, and delivers analytical instrumentation to a broad spectrum of industrial clients, encompassing chemical, semiconductor, electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment specializes in providing essential instruments, reagents, assay platforms, and software products for the early identification of genetic disorders, particularly during pregnancy and early childhood, as well as for infectious disease screening. Its product range facilitates the testing and detection of various genetic abnormalities and conditions, such as Down syndrome, hypothyroidism, muscular dystrophy, infertility, and diverse metabolic disorders. Moreover, this segment develops enabling technologies that support advanced genomic workflows, leveraging methods like G-protein coupled receptor (GPCR) analysis and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery research. PerkinElmer's client base is diverse, including pharmaceutical and biotechnology companies, research laboratories, academic and scientific institutions, public health organizations, private healthcare providers, medical professionals, and governmental agencies. Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts.
Key Executives
| Name | Position |
|---|---|
| Prahlad R. Singh | Chief Executive Officer, Pres & Director |
| Maxwell Krakowiak | Senior Vice President & Chief Financial Officer |
| Andrew Okun | Vice President, Chief Accounting Officer & Treasurer |
| Daniel R. Tereau | Senior Vice President of Strategy & Bus. Devel. |
| Joel S. Goldberg | Senior Vice President of Admin., Gen. Counsel & Sec. |
| Masoud Toloue | Senior Vice President of Diagnostics |
| Miriame Victor | Senior Vice President & Chief Commercial Officer |
| Robert Francis Friel | Advisor |
| Stephen Barr Willoughby | Senior Vice President of Investor Relations & Head of ESG |
| Tajinder Vohra | Senior Vice President of Global Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 02, 2026 | 4 | Filing |
| Sep 23, 2026 | 4 | Filing |
| Sep 18, 2026 | 4 | Filing |
| Sep 08, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 25, 2026 | 4 | Filing |
| Aug 18, 2026 | 4 | Filing |
| Aug 17, 2026 | 4 | Filing |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 14, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 11, 2026 | 10-Q | Quarterly Report |
PerkinElmer Inc.

| Country | United States |
| IPO Date | Apr 6, 1983 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 16,700 |
| CEO | Prahlad R. Singh |
Contact Details
940 Winter Street Waltham,
Massachusetts 02451 United States
Stock Details
| Ticker Symbol | PKI |
| Exchange | NYSE |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000031791 |
| CUSIP Number | 714046109 |
| ISIN Number | US7140461093 |
| SIC Code | 3826 |
Add to Watchlist
Select watchlists to add or remove PKI